Sihver_1999_J.Pharmacol.Exp.Ther_290_917

Reference

Title : Quantitative autoradiography with short-lived positron emission tomography tracers: a study on muscarinic acetylcholine receptors with N-[(11)C]methyl-4-piperidylbenzilate - Sihver_1999_J.Pharmacol.Exp.Ther_290_917
Author(s) : Sihver S , Sihver W , Bergstrom M , Hoglund AU , Sjoberg P , Langstrom B , Watanabe Y
Ref : Journal of Pharmacology & Experimental Therapeutics , 290 :917 , 1999
Abstract :

The present work demonstrates quantitative autoradiography by using positron emission tomography tracers and storage phosphorimaging plates. The uptake and association of [(11)C]N-methyl-4-piperidylbenzilate was measured in rat brain tissue cryosections of various thicknesses. The signal increased with increasing section thickness, but only in 10-micrometer-thick sections did the binding reach the steady state during a 50-min observation time. This violation of the equilibrium condition, potentially combined with perfusion limitations, leads to erroneous increased binding-site density and decreased affinity in the 25- and 50-micrometer-thick sections. For better imaging of receptor distribution it is reasonable to use thicker sections. For quantitative analysis of receptor-binding parameters, the specific properties of ligands at different thicknesses of cryosections need to be considered. Evidence is provided that the nonselective muscarinic antagonist N-methyl-4-piperidylbenzilate binds preferentially to the M(4) subtype of muscarinic acetylcholine receptors.

PubMedSearch : Sihver_1999_J.Pharmacol.Exp.Ther_290_917
PubMedID: 10411609

Related information

Citations formats

Sihver S, Sihver W, Bergstrom M, Hoglund AU, Sjoberg P, Langstrom B, Watanabe Y (1999)
Quantitative autoradiography with short-lived positron emission tomography tracers: a study on muscarinic acetylcholine receptors with N-[(11)C]methyl-4-piperidylbenzilate
Journal of Pharmacology & Experimental Therapeutics 290 :917

Sihver S, Sihver W, Bergstrom M, Hoglund AU, Sjoberg P, Langstrom B, Watanabe Y (1999)
Journal of Pharmacology & Experimental Therapeutics 290 :917